Cenerimod

N/A

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameCenerimod
Drug Alias Name西奈莫德Sphingosine 1 phosphate receptor modulators - ActelionS1P1 receptor modulator - Actelion塞利莫德Sphingosine 1-phosphate receptor 1 agonists +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-Phosphate Receptor 1 modulators
TargetsSphingosine 1-Phosphate Receptor 1
Therapy Area/IndicationsLupus Erythematosus, SystemicRenal InsufficiencyLupus Nephritis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[36] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesIdorsia Pharmaceuticals LtdActelion Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesViatris Innovation GmbHViatris Innovation (Beijing) Pharmaceuticals Co LtdIdorsia Pharmaceuticals Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicRenal InsufficiencyLupus Nephritis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A